These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 4665516)

  • 1. [Mechanism of action of AR 3-ARDF 26, a new betacytotropic sulfonylurea derivative and tolbutamide].
    Zilker T; Bottermann P
    Verh Dtsch Ges Inn Med; 1972; 78():1275-8. PubMed ID: 4665516
    [No Abstract]   [Full Text] [Related]  

  • 2. [Immunoreactive insulin, nonesterified fatty acids and glucose in the serum following intravenous administration of glibornuride as compared to tolbutamide].
    Bottermann P; Souvatzoglou A; Schwarz K; Rettig M
    Verh Dtsch Ges Inn Med; 1971; 77():556-9. PubMed ID: 5155896
    [No Abstract]   [Full Text] [Related]  

  • 3. The effect of oral sulphonylureas on blood glucose and insulin.
    Adadevoh BK; Bolodeoku JO
    Ghana Med J; 1973 Dec; 12(4):360-5. PubMed ID: 4282692
    [No Abstract]   [Full Text] [Related]  

  • 4. [Action of the sulfonylureas tolbutamide and glypentide on the lacticdehydrogenase plasma levels (author's transl)].
    García-Rafanell J; Morell-Mestre J
    Rev Esp Fisiol; 1974 Jun; 30(2):91-6. PubMed ID: 4421448
    [No Abstract]   [Full Text] [Related]  

  • 5. Effects of chronic and acute treatment with sulfonylureas on plasma insulin and glucose levels in the rat.
    Codina J; Lasuncion MA; Herrera E
    Diabete Metab; 1978 Mar; 4(1):47-52. PubMed ID: 97105
    [No Abstract]   [Full Text] [Related]  

  • 6. [Extrapancreatic effects of sulfonylurea compounds. I. Studies on the effect of tolbutamide and glibornuride on blood sugar, nonesterified fatty acids, glycerin, lactate and pyruvate in the pancreatectomized dog chronically treated with insulin].
    Beyer J; Cordes U; Krall H; Sell G; Schöffling K
    Arzneimittelforschung; 1972 Dec; 22():Suppl 12A:2167. PubMed ID: 4679246
    [No Abstract]   [Full Text] [Related]  

  • 7. [Pharmacological aspects of comparative studies on different blood sugar-lowering sulfonylureas].
    Beyer J; Haupt E; Cordes U; Sell G; Schöffling K
    Arzneimittelforschung; 1973 Nov; 23(11):Suppl:1668-75. PubMed ID: 4205544
    [No Abstract]   [Full Text] [Related]  

  • 8. [Extrapancreatic effects of sulfonylurea compounds. II. Comparison of equimolar concentrations of tolbutamide, glibornuride, hydroxymethyltolbutamide, carboxytolbutamide, and carboxyglycylamide with reference to their blood-sugar-decreasing and antilipolytic effect on completely pancreatectomized dogs, chronically treated insulin].
    Beyer J; Cordes U; Sell G; Krall H; Schöffling K
    Arzneimittelforschung; 1972 Dec; 22():Suppl 12A:2172. PubMed ID: 4679247
    [No Abstract]   [Full Text] [Related]  

  • 9. Correlation among glucose, insulin, and orally administered SPC-703 blood-levels in rats and rabbits.
    Wójcikowski C; Strzelecki T; Szlabowicz D
    Pol J Pharmacol Pharm; 1975; 27(1):45-52. PubMed ID: 1114135
    [No Abstract]   [Full Text] [Related]  

  • 10. [Experimental studies on mechanism of inhibition of thrombocyte aggregation caused by sulfonyl ureas. 1. Problems and methods].
    Scholz Ch; Losert W; Hoder A
    Arzneimittelforschung; 1975 Jan; 25(1):38-46. PubMed ID: 167791
    [No Abstract]   [Full Text] [Related]  

  • 11. Effect of intravenous glibornuride and tolbutamide on myocardial contractility.
    Dubach UC; Burckhardt D; Raeder EA; Forgo I; Amrein R; Bückert A
    Cardiology; 1979; 64(4):208-14. PubMed ID: 157810
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glipizide: experimental study and comparison with other sulfonylureas.
    Loubatieres-Mariani MM
    Acta Endocrinol Suppl (Copenh); 1980; 239():26-32. PubMed ID: 6776761
    [No Abstract]   [Full Text] [Related]  

  • 13. [Betacytotropic and antilipolytic effect of critical doses of tolbutamide and glibenclamide].
    Rosak C; Haupt E; Bartelt KM; Beyer J; Schöffling K
    Verh Dtsch Ges Inn Med; 1972; 78():1278-81. PubMed ID: 4198781
    [No Abstract]   [Full Text] [Related]  

  • 14. [Comparative use of gliquidone and tolbutamide administered intravenously].
    Zilker T; Lüders L; Bottermann P
    MMW Munch Med Wochenschr; 1975 Sep; 117(36):1421-2. PubMed ID: 126376
    [No Abstract]   [Full Text] [Related]  

  • 15. [Insulin and pro-insulin secretion following intravenous administration of tolbutamide, glisoxepide and glibenclamide].
    Hausmann L; Schumann G; Kaffarnik H
    Arzneimittelforschung; 1978; 28(1):83-6. PubMed ID: 415745
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of sulphonylurea derivatives, SPC-703 and tolbutamide, on insulin binding by isolated rat adipocytes.
    Skowroński R; Madrala A; Angielski S
    Acta Biochim Pol; 1984; 31(2):251-62. PubMed ID: 6385586
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of sulfonylureas and clofibrate on insulin receptors in cultured human lymphocytes.
    Zeng SF; Yokono K; Baba S
    Kobe J Med Sci; 1985 Aug; 31(4):169-82. PubMed ID: 3906258
    [No Abstract]   [Full Text] [Related]  

  • 18. A clinical study of the metabolic effect of a new oral hypoglycemic agent: glipizide.
    Iacono G; Ghionni A; Colucci M; Verde G; Caputo G
    Int J Clin Pharmacol; 1974 Apr; 7(3):225-31. PubMed ID: 4850166
    [No Abstract]   [Full Text] [Related]  

  • 19. Investigation of the effects of sulfonylurea exposure on pancreatic beta cell metabolism.
    Brennan L; Hewage C; Malthouse JP; McClenaghan NH; Flatt PR; Newsholme P
    FEBS J; 2006 Nov; 273(22):5160-8. PubMed ID: 17054712
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Extrapancreatic effects of oral sulfonylureas].
    Beyer J; Cordes U; Krall H; Rosak C; Schöffling K
    Verh Dtsch Ges Inn Med; 1971; 77():539-43. PubMed ID: 5155894
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.